{"nct_id":"NCT06295731","title":"INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2024-05-14","start_date_type":"ACTUAL","primary_completion_date":"2029-05","primary_completion_date_type":"ESTIMATED","completion_date":"2029-05","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["INBX"]}